N
NextCure, Inc. (NXTC)
NMS – Real Time Price. Currency in USD
9.78
0.00 (0.00%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
9.78
0.00 (0.00%)
At close: May 12, 2026, 4:00 PM EDT
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer. The company’s product candidate is the LNCB74, a B7-H4 targeted ADC to kill tumors. It also develops NC410, a fusion protein of LAIR-2, that is designed to block immune suppression mediated by LAIR-1; NC525, a novel LAIR-1 antibody that targets acute myeloid leukemia, blast cells, and leukemic stem cells; NC181 a humanized antibody targeting ApoE4 for the treatment of Alzheimer’s disease; and NC605 an antibody that targets Siglec-15, as well as chronic bone diseases, such as osteoarthritis and non-union fractures. The company also develop SIM0505, a novel antibody-drug conjugate (ADC) targeting CDH6 (cadherin-6 or K-cadherin) for the treatment of solid tumors. The company was incorporated in 2015 and is headquartered in Beltsville, Maryland.
| Name | Position |
|---|---|
| Dr. Lieping Chen M.D., Ph.D. | Co-Founder & Chairman of Scientific Advisory Board |
| Dr. Sebastien Maloveste Ph.D. | Senior Vice President of Business Development |
| Dr. Timothy Mayer Ph.D. | Chief Operating Officer |
| Dr. Udayan Guha M.D., Ph.D. | Chief Medical Officer |
| Mr. Kevin G. Shaw | Senior VP & General Counsel |
| Mr. Michael S. Richman MSBA | Co-Founder, CEO, President & Director |
| Mr. Sourav Kundu Ph.D. | Senior Vice President of Development & Manufacturing |
| Mr. Steven P. Cobourn CPA | Chief Financial Officer |
| Date | Type | Document |
|---|---|---|
| 2026-05-07 | 10-Q | nxtc-20260331x10q.htm |
| 2026-04-24 | DEFA14A | tm261451d5_defa14a.htm |
| 2026-04-24 | DEF 14A | tm261451-3_def14a.htm |
| 2026-03-05 | 8-K | nxtc-20260305x8k.htm |
| 2026-01-23 | 8-K | nxtc-20260123x8k.htm |
| 2025-12-19 | 8-K | tm2533962d1_8k.htm |
| 2025-12-10 | D | |
| 2025-11-26 | S-3 | tm2532242-1_s3.htm |
| 2025-11-17 | 8-K | nxtc-20251112x8k.htm |
| 2025-11-05 | 8-K | nxtc-20251105x8k.htm |